Johan M. Spoor Insider Profile

4 Followers
Johan M. Spoor, Director at Entero Therapeutics, holds 207.57K shares in Perspective Therapeutics (Ticker: CATX), holds 378.47K shares in Entero Therapeutics (Ticker: ENTO). Most recently, Johan M. Spoor Bought ― shares of Perspective Therapeutics on Jun 13, 2024 for an estimated value of 117.00K.
tipranks
Johan M. Spoor

Johan M. Spoor
Entero Therapeutics (ENTO)
Director

Ranked #64,602 out of 99,218 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-12.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
89.97%
10.03%
A breakdown of Johan M. Spoor's holdings

Insider Roles

Perspective Therapeutics
(CATX)
CEO, Director
Entero Therapeutics
(ENTO)
Director
Roles that Johan M. Spoor holds in companies

Most Profitable Insider Trade

Stock:
Perspective Therapeutics
(CATX)
Rating:Informative Buy
Date:Jun 13, 2024 - Today
Return:+4.20%
The most profitable trade made by Johan M. Spoor

Johan M. Spoor's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Entero Therapeutics
Jan 02, 2019
Director
Informative Buy
49.77K
$260.39K
Perspective Therapeutics
Jun 13, 2024
CEO, Director
Informative Buy
117.00K
$2.34M
List of latest transactions for each holding click on a transaction to see Johan M. Spoor's performance on stock

Johan M. Spoor insider profile FAQ

What is the percentage of profitable transactions made by Johan M. Spoor?
The percentage of profitable transactions made by Johan M. Spoor is 33%.
    What is the average return per transaction made by Johan M. Spoor?
    The average return per transaction made by Johan M. Spoor is -12.40%.
      What stocks does Johan M. Spoor hold?
      Johan M. Spoor holds: ENTO, CATX stocks.
        What was Johan M. Spoor’s latest transaction?
        Johan M. Spoor latest transaction was an Informative Buy of $117.00K.
          What was Johan M. Spoor's most profitable transaction?
          Johan M. Spoor’s most profitable transaction was an Informative Buy of CATX stock on June 13, 2024. The return on the trade was 4.20%.
            What is Johan M. Spoor's role in Entero Therapeutics?
            Johan M. Spoor's role in Entero Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.